CY1120964T1 - Ετερογενη εμφυτευσιμα προϊοντα για χορηγηση φαρμακων - Google Patents
Ετερογενη εμφυτευσιμα προϊοντα για χορηγηση φαρμακωνInfo
- Publication number
- CY1120964T1 CY1120964T1 CY181101276T CY181101276T CY1120964T1 CY 1120964 T1 CY1120964 T1 CY 1120964T1 CY 181101276 T CY181101276 T CY 181101276T CY 181101276 T CY181101276 T CY 181101276T CY 1120964 T1 CY1120964 T1 CY 1120964T1
- Authority
- CY
- Cyprus
- Prior art keywords
- core
- drug
- layer
- additional
- medicament
- Prior art date
Links
- 238000001647 drug administration Methods 0.000 title 1
- 239000007943 implant Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 8
- 239000011162 core material Substances 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 5
- 239000000463 material Substances 0.000 abstract 3
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 229940088679 drug related substance Drugs 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31446510P | 2010-03-16 | 2010-03-16 | |
| PCT/US2011/028727 WO2011116132A1 (en) | 2010-03-16 | 2011-03-16 | Heterogeneous implantable devices for drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1120964T1 true CY1120964T1 (el) | 2019-12-11 |
Family
ID=44649589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY181101276T CY1120964T1 (el) | 2010-03-16 | 2018-11-29 | Ετερογενη εμφυτευσιμα προϊοντα για χορηγηση φαρμακων |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US10111830B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2547332B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5869551B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101914119B1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011227289B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2792179C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1120964T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2547332T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2699200T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20182014T1 (cg-RX-API-DMAC7.html) |
| LT (1) | LT2547332T (cg-RX-API-DMAC7.html) |
| MX (1) | MX354444B (cg-RX-API-DMAC7.html) |
| PL (1) | PL2547332T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2547332T (cg-RX-API-DMAC7.html) |
| RS (1) | RS58011B1 (cg-RX-API-DMAC7.html) |
| SG (2) | SG184059A1 (cg-RX-API-DMAC7.html) |
| SI (1) | SI2547332T1 (cg-RX-API-DMAC7.html) |
| SM (1) | SMT201800629T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011116132A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101914119B1 (ko) | 2010-03-16 | 2018-11-02 | 타이탄 파머슈티컬즈 인코퍼레이티드 | 약물 전달용 이종 이식가능 장치 |
| MX350469B (es) * | 2011-10-24 | 2017-09-07 | Endo Pharmaceuticals Solutions | Composiciones para el suministro de farmacos implantables y metodos para su tratamiento. |
| EP2770981B1 (en) | 2011-10-24 | 2017-05-24 | Braeburn Pharmaceuticals, Inc. | Implantable tizanidine compositions and methods of treatment thereof |
| JP2014530913A (ja) * | 2011-10-24 | 2014-11-20 | エンドゥ ファーマシューティカルズ ソリューションズ インコーポレイティド | 移植可能ラサギリン組成物及びその治療方法 |
| TW201332585A (zh) | 2012-02-14 | 2013-08-16 | Chemo Res S L | 核鞘藥物遞送裝置 |
| CN102731777B (zh) * | 2012-07-06 | 2013-12-18 | 辽宁大学 | 聚l-谷氨酸-苄酯/聚磷酸乙酯嵌段共聚物的合成方法 |
| EP3148494A4 (en) * | 2014-05-30 | 2017-12-20 | Textile-Based Delivery, Inc. | Drug delivery systems and related methods of use |
| CN107205956A (zh) | 2014-10-30 | 2017-09-26 | 纺织品技术股份有限公司 | 输送系统 |
| KR101693696B1 (ko) * | 2015-06-12 | 2017-01-06 | 한국생산기술연구원 | 지혈용 다공성 구조체 및 그의 제조 방법 |
| PT109154B (pt) * | 2016-02-12 | 2019-11-05 | Univ De Coimbra | Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos |
| GB201603296D0 (en) | 2016-02-25 | 2016-04-13 | Ucl Business Plc | Chemotactic,drug-containing polymersomes |
| GB201604553D0 (en) | 2016-03-17 | 2016-05-04 | Ucl Business Plc | Fumarate polymersomes |
| BR112018072883B1 (pt) * | 2016-05-12 | 2023-01-17 | Merck Sharp & Dohme Llc | Sistema de implante subdérmico do agente antiviral 4'-etinil-2-fluoro-2'-desoxiadenosina com polímero eva e seu uso |
| KR102637575B1 (ko) * | 2016-10-05 | 2024-02-20 | 타이탄 파머슈티컬즈 인코퍼레이티드 | 버스트 방출이 감소된 약물 전달용 이식 가능한 장치 |
| IT201700101582A1 (it) * | 2017-09-12 | 2019-03-12 | Milano Politecnico | Dispositivo per rilascio intraoculare |
| CN108310455B (zh) * | 2018-03-20 | 2021-07-30 | 嘉兴尔云信息科技有限公司 | 纳米羟基磷灰石、pgs-m复合骨修复材料及其制备方法 |
| CN119236191A (zh) * | 2018-05-24 | 2025-01-03 | 塞拉尼斯伊娃高性能聚合物公司 | 用于持续释放大分子药物化合物的可植入器件 |
| WO2019222856A1 (en) | 2018-05-24 | 2019-11-28 | Nureva Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
| CA3087238A1 (en) * | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
| EP3810092A4 (en) * | 2018-06-25 | 2022-04-20 | Titan Pharmaceuticals, Inc. | LOADED POROUS STRUCTURES FOR USE AS IMPLANTS |
| CA3123747A1 (en) | 2019-01-07 | 2020-07-16 | Ucl Business Ltd | Polymersomes functionalised with multiple ligands |
| EP3915614A4 (en) * | 2019-01-25 | 2022-09-28 | Daicel Corporation | CRACK RESISTANT COMPONENT |
| KR102183669B1 (ko) * | 2019-03-26 | 2020-11-26 | 가톨릭대학교 산학협력단 | 이중 약물 방출을 위한 약물 전달체 |
| US20200375245A1 (en) * | 2019-05-31 | 2020-12-03 | Bio-On S.P.A. | Filter elements suitable for use in smoking articles and processes for producing the same |
| BR102020013862A2 (pt) * | 2020-07-07 | 2022-01-18 | Edson Luiz Peracchi | Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson |
| US20240165064A1 (en) * | 2021-03-29 | 2024-05-23 | Edson Luiz Peracchi | Long-lasting resorbable subcutaneous implant with prolonged release of pre-concentrated pharmacologically active substance in polymer for the treatment of hypothyroidism, and method |
| WO2022221862A1 (en) * | 2021-04-14 | 2022-10-20 | Titan Pharmaceuticals, Inc. | Kappa-opioid receptor agonist implants for treatment of pruritus |
| BR112023022439A2 (pt) | 2021-04-26 | 2023-12-26 | Celanese Eva Performance Polymers Llc | Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular |
| CN113209050A (zh) * | 2021-05-14 | 2021-08-06 | 浙江恒冀制药有限责任公司 | 基于生物相容性聚合物的长效体内皮埋或内植缓释制剂 |
| EP4433035A1 (en) * | 2021-11-17 | 2024-09-25 | Celanese EVA Performance Polymers LLC | Implantable device for treating an inflammatory eye condition |
| US20230404907A1 (en) * | 2022-06-13 | 2023-12-21 | Celanese Eva Performance Polymers Llc | Monolithic Implantable Device for Sustained Release of an Antibody |
| GB202304657D0 (en) * | 2023-03-29 | 2023-05-10 | Univ Liverpool | Atovaquine compositions |
| WO2024238703A1 (en) * | 2023-05-16 | 2024-11-21 | Elixir Medical Corporation | Anticoagulant compositions comprising anti-platelet and anti-inflammatory drugs and methods and devices for their use |
| GB202401392D0 (en) | 2024-02-02 | 2024-03-20 | Imphatec Ltd | Implant for delivery of a drug |
| WO2025174767A1 (en) * | 2024-02-13 | 2025-08-21 | Biraj Investments, Llc | Highly loaded implantable devices with high tensile strength for drug delivery |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4379117A (en) | 1961-12-05 | 1983-04-05 | W. R. Grace & Co. | Method for preparing a film of vinylidene chloride polymer |
| US3337665A (en) | 1964-10-12 | 1967-08-22 | Union Carbide Corp | Method for the production of thermoplastic film |
| US3625214A (en) | 1970-05-18 | 1971-12-07 | Alza Corp | Drug-delivery device |
| DE2114065C2 (de) | 1971-03-23 | 1982-08-19 | Heinrich Pannenbecker | Verfahren zur Herstellung von Folien aus thermoplastischen Kunststoffen mit Klebereigenschaft |
| US3920805A (en) * | 1971-12-09 | 1975-11-18 | Upjohn Co | Pharmaceutical devices and method |
| US3926188A (en) | 1974-11-14 | 1975-12-16 | Alza Corp | Laminated drug dispenser |
| CA1076480A (en) * | 1975-04-28 | 1980-04-29 | John S. Kent | Inert core implant pellet |
| US4191741A (en) | 1978-09-22 | 1980-03-04 | Eli Lilly And Company | Removable drug implant |
| IT1177349B (it) | 1984-11-28 | 1987-08-26 | Prandi G & C Off Mec | Testa di coestrusione circolare di piu' strati di materiali termoplastici |
| US4693886A (en) * | 1985-04-22 | 1987-09-15 | Alza Corporation | Osmotic device with inert core |
| US5601835A (en) | 1987-04-29 | 1997-02-11 | Massachusetts Institute Of Technology | Polymeric device for controlled drug delivery to the CNS |
| US4883666A (en) | 1987-04-29 | 1989-11-28 | Massachusetts Institute Of Technology | Controlled drug delivery system for treatment of neural disorders |
| US5114719A (en) | 1987-04-29 | 1992-05-19 | Sabel Bernhard A | Extended drug delivery of small, water-soluble molecules |
| US5063018A (en) | 1990-06-04 | 1991-11-05 | Cordis Corporation | Extrusion method |
| US5683719A (en) | 1990-11-22 | 1997-11-04 | British Technology Group Limited | Controlled release compositions |
| AU6360896A (en) | 1995-07-04 | 1997-02-05 | Akzo Nobel N.V. | Ring-shaped devices |
| US5733565A (en) | 1996-02-23 | 1998-03-31 | The Population Council, Center For Biomedical Research | Male contraceptive implant |
| DE19608423A1 (de) * | 1996-03-05 | 1997-09-11 | Merck Patent Gmbh | Implantate mit phasenweiser Arzneistoffabgabe |
| US20030059471A1 (en) | 1997-12-15 | 2003-03-27 | Compton Bruce Jon | Oral delivery formulation |
| TW586944B (en) | 1998-05-29 | 2004-05-11 | Sumitomo Pharma | Controlled release agent having a multi-layer structure |
| US6117441A (en) * | 1998-07-02 | 2000-09-12 | The Population Council, Inc. | Silicone core long term androgen delivery implant |
| US6258121B1 (en) | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
| US6585765B1 (en) | 2000-06-29 | 2003-07-01 | Advanced Cardiovascular Systems, Inc. | Implantable device having substances impregnated therein and a method of impregnating the same |
| US6506437B1 (en) | 2000-10-17 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device having depots formed in a surface thereof |
| US6713081B2 (en) * | 2001-03-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Ocular therapeutic agent delivery devices and methods for making and using such devices |
| US6780424B2 (en) | 2001-03-30 | 2004-08-24 | Charles David Claude | Controlled morphologies in polymer drug for release of drugs from polymer films |
| EP1441703B1 (en) * | 2001-10-29 | 2018-01-03 | Massachusetts Institute of Technology | Zero-order release profile dosage form manufactured by three-dimensional printing |
| AU2003240493B2 (en) * | 2002-05-31 | 2008-06-12 | L. Molteni & C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. | Implantable polymeric device for sustained release of buprenorphine |
| DE602004031512D1 (de) | 2003-03-31 | 2011-04-07 | Titan Pharmaceuticals Inc | Polymeres implantat zur verzögerten freisetzung von dopamin antagonisten |
| US20050031668A1 (en) * | 2003-05-30 | 2005-02-10 | Patel Rajesh A. | Implantable polymeric device for sustained release of nalmefene |
| US8313763B2 (en) | 2004-10-04 | 2012-11-20 | Tolmar Therapeutics, Inc. | Sustained delivery formulations of rapamycin compounds |
| KR100511618B1 (ko) | 2005-01-17 | 2005-08-31 | 이경범 | 약물방출 조절형 다층 코팅 스텐트 및 이의 제조방법 |
| DE102005034453A1 (de) * | 2005-07-23 | 2007-01-25 | Voith Patent Gmbh | Verfahren zur Herstellung eines Papiermaschinensiebes |
| US20090022806A1 (en) | 2006-12-22 | 2009-01-22 | Mousa Shaker A | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof |
| WO2007139744A2 (en) | 2006-05-23 | 2007-12-06 | Titan Pharmaceuticals, Inc. | Implantable polymeric device for sustained release of buprenorphine with minimal initial burst |
| US20100203104A1 (en) | 2006-11-22 | 2010-08-12 | N.V. Organon | Delivery system for risperidone |
| AR066166A1 (es) | 2007-09-21 | 2009-07-29 | Organon Nv | Sistema de suministro de droga |
| WO2010009335A1 (en) * | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
| US20100040671A1 (en) * | 2008-08-12 | 2010-02-18 | Ahmed Salah U | Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof |
| CA2755828A1 (en) * | 2009-03-17 | 2010-09-23 | Intervet International B.V. | Zoo-technical drug delivery device |
| KR101914119B1 (ko) | 2010-03-16 | 2018-11-02 | 타이탄 파머슈티컬즈 인코퍼레이티드 | 약물 전달용 이종 이식가능 장치 |
-
2011
- 2011-03-16 KR KR1020127026810A patent/KR101914119B1/ko not_active Expired - Fee Related
- 2011-03-16 LT LTEP11756957.4T patent/LT2547332T/lt unknown
- 2011-03-16 PT PT11756957T patent/PT2547332T/pt unknown
- 2011-03-16 AU AU2011227289A patent/AU2011227289B2/en active Active
- 2011-03-16 SM SM20180629T patent/SMT201800629T1/it unknown
- 2011-03-16 US US13/634,535 patent/US10111830B2/en active Active
- 2011-03-16 SG SG2012067989A patent/SG184059A1/en unknown
- 2011-03-16 RS RS20181407A patent/RS58011B1/sr unknown
- 2011-03-16 PL PL11756957T patent/PL2547332T3/pl unknown
- 2011-03-16 MX MX2012010611A patent/MX354444B/es active IP Right Grant
- 2011-03-16 HR HRP20182014TT patent/HRP20182014T1/hr unknown
- 2011-03-16 DK DK11756957.4T patent/DK2547332T3/en active
- 2011-03-16 JP JP2013500190A patent/JP5869551B2/ja not_active Expired - Fee Related
- 2011-03-16 WO PCT/US2011/028727 patent/WO2011116132A1/en not_active Ceased
- 2011-03-16 ES ES11756957T patent/ES2699200T3/es active Active
- 2011-03-16 SG SG10201501964QA patent/SG10201501964QA/en unknown
- 2011-03-16 SI SI201131621T patent/SI2547332T1/sl unknown
- 2011-03-16 CA CA2792179A patent/CA2792179C/en active Active
- 2011-03-16 EP EP11756957.4A patent/EP2547332B1/en active Active
-
2013
- 2013-03-13 US US13/802,504 patent/US10123971B2/en active Active
- 2013-03-13 US US13/802,526 patent/US20130195951A1/en not_active Abandoned
- 2013-03-13 US US13/802,539 patent/US20130202673A1/en not_active Abandoned
-
2015
- 2015-08-12 JP JP2015159516A patent/JP6022649B2/ja not_active Expired - Fee Related
-
2018
- 2018-11-29 CY CY181101276T patent/CY1120964T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2547332A4 (en) | 2014-04-16 |
| AU2011227289A1 (en) | 2012-09-27 |
| RS58011B1 (sr) | 2019-02-28 |
| CA2792179A1 (en) | 2011-09-22 |
| CA2792179C (en) | 2019-04-02 |
| MX354444B (es) | 2018-03-06 |
| US10111830B2 (en) | 2018-10-30 |
| US20130189342A1 (en) | 2013-07-25 |
| SG184059A1 (en) | 2012-10-30 |
| US10123971B2 (en) | 2018-11-13 |
| SMT201800629T1 (it) | 2019-01-11 |
| WO2011116132A1 (en) | 2011-09-22 |
| KR101914119B1 (ko) | 2018-11-02 |
| DK2547332T3 (en) | 2018-12-17 |
| KR20130038840A (ko) | 2013-04-18 |
| HRP20182014T1 (hr) | 2019-01-25 |
| US20130202673A1 (en) | 2013-08-08 |
| PT2547332T (pt) | 2018-11-27 |
| PL2547332T3 (pl) | 2019-07-31 |
| EP2547332B1 (en) | 2018-08-29 |
| MX2012010611A (es) | 2013-02-21 |
| SI2547332T1 (sl) | 2019-01-31 |
| JP5869551B2 (ja) | 2016-02-24 |
| SG10201501964QA (en) | 2015-05-28 |
| AU2011227289B2 (en) | 2016-01-21 |
| JP2013522314A (ja) | 2013-06-13 |
| US20130195950A1 (en) | 2013-08-01 |
| JP2015227371A (ja) | 2015-12-17 |
| ES2699200T3 (es) | 2019-02-07 |
| JP6022649B2 (ja) | 2016-11-09 |
| US20130195951A1 (en) | 2013-08-01 |
| LT2547332T (lt) | 2018-12-10 |
| EP2547332A1 (en) | 2013-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120964T1 (el) | Ετερογενη εμφυτευσιμα προϊοντα για χορηγηση φαρμακων | |
| CY1117916T1 (el) | Θεραπεια διαταραχων που σχετιζονται me bdnf χρησιμοποιωντας laquinimod | |
| CY1123688T1 (el) | Μεθοδοι για τη θεραπευτικη αντιμετωπιση ογκων χρησιμοποιωντας αμφιειδικο αντισωμα cd3xcd20 | |
| CY1123162T1 (el) | Ελεγχομενης αποδεσμευσης φαρμακευτικα σκευασματα νιταζοξανιδης | |
| CY1119649T1 (el) | Ταχεια παγιωση και/'η περατωση της ουσιαστικης απελευθερωσης φαρμακου σταθεροποιημενης-καταστασης | |
| MX2019011117A (es) | Anticuerpo b7-h3, fragmento de union a antigeno de los mismos y uso medico de los mismos. | |
| UA106593C2 (uk) | Пристрій для пролонгованого введення ліків, який містить полімери на основі поліуретану, та спосіб його виготовлення | |
| MX2014010913A (es) | Composicion farmaceutica que comprende farmaco empagliflozina y antiobesidad. | |
| EP4389213A3 (en) | Treatment of fabry disease in ert-naive and ert-experienced patients | |
| CY1122716T1 (el) | Ρινικη συσταση κονεως για την αγωγη της υπογλυκαιμιας | |
| WO2009148777A3 (en) | Implantable drug delivery devices having alternating hydrophilic and amphiphilic polymer layers | |
| MX2019003173A (es) | Terapia de combinacion con agonistas de peptido natriuretico tipo c (cnp) de liberacion controlada. | |
| MX2015007714A (es) | Agente terapeutico de direccionamiento a glipicano 3 (gpc3) que es administrado a pacientes para quienes la terapia con agentes terapeuticos de direccionamiento a gpc3 es eficaz. | |
| CY1116638T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας | |
| MX361778B (es) | Composiciones farmaceuticas y metodos de tratamiento. | |
| CY1123583T1 (el) | Ανοσογονος συνθεση για χρηση στη θεραπεια | |
| BR112013010829A2 (pt) | composição farmacêutica intravenenosa para proporcionar alívio da dor e / ou da inflamação, uso e método da mesma | |
| AU2018326364A1 (en) | Methods of enhancing and/or stabilizing cardiac function in patients with Fabry disease | |
| MX2019015676A (es) | Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento. | |
| CY1115223T1 (el) | Αντι-μελαγχολικο φαρμακο που παρασκευαζεται με υλικα camp απο τζιτζιφα | |
| CY1117483T1 (el) | Συνθεσεις τροποποιημενης αποδεσμευσης επαλρεστατης ή ενος παραγωγου αυτης και μεθοδοι για χρηση των ιδιων | |
| BR112015011294A8 (pt) | nanopartículas com polímero biodegradável e biocompatível plga carregadas com o fármaco pentoxifilina de uso humano e uso destas | |
| CY1120727T1 (el) | Συνδυασμοι με ενα πεπτιδιο κυκλοποιημενου σκελετου | |
| WO2019067768A3 (en) | FIXED DOSE COMBINATION FORMULATIONS FOR THE TREATMENT OF PAIN | |
| ATE408670T1 (de) | Autologous selbst-toleranz induzierende zellen monozytären ursprungs und ihren verwendung in artzneimitteln |